Utilizing atypical wake-promoting agent modafinil (inactive in both rH(3) and hH(3) binding assays) as a launching pad, a series of sulfinyl- and sulfone-derived H(3) receptor inverse agonists were developed. Brain-permeable compound 27, a potent member of the series displayed excellent selectivity against related family members (H(1), H(2), and H(4) receptors).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/cbdd.12094 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!